The surgical treatment of cervical disc protrusions in the dog: a review of 40 cases

The case histories of 40 dogs with cervical disc protrusions are described. In each case fenestration of the affected disc and prophylactic fenestration of the other cervical discs was carried out. The results of treatment are presented.     

The lateral fenestration of canine thoracolumbar disc protrusions: a review of 30 cases

Thirty dogs with disc protrusions in the thoracolumbar region were treated by lateral fenestration of the last three thoracic and first three lumbar discs. The case details and results of treatment are presented.     

Effectiveness of cervical hemilaminectomy in canine Hansen Type I and Type II disc disease: a retrospective study

Medical records of 41 dogs, including 15 small breed dogs (<15 kg) and 26 large breed dogs (>15 kg), with cervical intervertebral disc disease (IVDD) that underwent a hemilaminectomy were reviewed. Dogs were diagnosed using myelography, computed tomography/myelography, or MRI, and dogs were classified as having either Hansen Type I disc extrusion or Hansen Type II disc protrusion located ventrally, ventrolaterally, or laterally within the cervical spinal canal. The most common clinical presentation was ambulatory tetraparesis and/or lameness (44%). The most affected sites for cervical IVDD were between the sixth and seventh cervical vertebrae (C6-C7; 78% of Hansen Type II discs) and C2-C3 (86% of Hansen Type I discs). Treatment was effective in 88% of dogs. Five large breed dogs (12%) did not improve. In dogs with a Hansen Type I disc extrusion, clinical signs improved in 96% of the cases. In dogs with a Hansen Type II disc protrusion, an excellent and good outcome was seen in 47% and 32% of cases, respectively. Outcome was significantly better for small breed dogs and dogs with Hansen Type I disc disease compared with large breed dogs and dogs with Hansen Type II disc disease.     

The radiological features of canine Cushing's syndrome: a review of forty-eight cases

The radiological signs which have been reported in association with canine Cushing's syndrome are reviewed. The incidence of these changes in 48 dogs affected with this condition is reported and the contribution of radiography to diagnosis, prognosis and management is discussed.     

Intervertebral disc disease of the cervical and cranial thoracic vertebrae in equidae: eight cases

Intervertebral disc disease in the cervical and cranial thoracic vertebrae is unusual in horses and the majority of documented cases have been associated with infection and resulted in ataxia. The current retrospective study documents the clinical and imaging features, and outcome in eight Equidae with neck stiffness ± forelimb lameness (n = 3) or ataxia (n = 2) assessed during a 10-year period at two clinics. The Equidae (one donkey and seven horses) ranged in age from 1.5 to 12 years (median 5.5 years). The duration of clinical signs ranged from 1 to 6 months (median 1.5 months). The donkey had a depressed demeanour. All Equidae had reduced range of neck movement. The donkey and one horse showed mild and severe ataxia respectively. Two horses showed a propensity to stumble on each forelimb, one of which exhibited forelimb lameness on the lunge or ridden. Two additional horses showed lameness in hand. One horse experienced ‘neck locking’ during grazing. Radiological abnormalities were identified involving the intervertebral symphysis between the sixth cervical vertebra (C6) and C7 in four Equidae; in two horses the articulation between C7 and the first thoracic vertebra (T1) was involved. One horse had abnormalities of the intervertebral symphyses of both C7 and T1, and T1 and T2. In one horse the articulation between C2 and 3 was affected. The donkey was treated with a prolonged course of doxycycline and improved. An advanced dressage horse returned to full-function after surgical fusion of the affected intervertebral symphysis. Intervertebral disc disease is a rare cause of neck stiffness ± lameness or ataxia.     

Conservative and surgical treatment of canine acetabular fractures: A review of 34 cases

The case histories of 34 dogs with acetabular fractures are reviewed. Twenty-one were treated surgically and 13 conservatively. A classification system for acetabular fractures is presented and the results of treatment in each group are described and discussed.     

The assessment of corrective surgery for canine laryngeal paralysis by blood gas analysis: a review of thirty-five cases

Arterial blood samples were collected under sedation, from the femoral artery of 35 dogs suffering from laryngeal paralysis. Pre-operatively, the dogs showed a moderate degree of arterial hypoxaemia (mean PaO₂ 77 mmHg), with the worst affected clinically showing the most severe hypoxia. Following corrective surgery there was a significant improvement in PaO₂ tensions (90 mmHg). A group of 20 control dogs were also sedated and sampled. Their mean arterial oxygen tension was 91 mmHg, indicating that the pre-operative hypoxaemia found in the dogs with laryngeal paralysis was not the result of sedation.     

Thoracolumbar disc disease in large dogs: a study of 99 cases

The records of 99 dogs weighing over 20 kg with thoracolumbar disc disease were reviewed. Two types of disc disease were recognised: degenerative nuclear extrusion (n=63) and degenerative annular protrusion (n=36). Sixty-nine per cent of the affected discs were located between T12-T13 and L2-L3. Of the 63 dogs with degenerative nuclear extrusions, 35 were non-ambulatory and seven had no conscious pain perception at the time of presentation. Decompressive surgery was performed in 55 dogs, four dogs were managed non-surgically and three dogs were euthanased. A successful outcome was achieved in 49 (78 per cent) cases as assessed by the authors and in 53 (84 per cent) cases as assessed by the owners. Mean follow-up time was 11.7 months (range 1.5 to 48 months). Five dogs subsequently lost the ability to ambulate on their hindlimbs. Myelographic investigations in three of these dogs revealed a second thoracolumbar degenerative nuclear extrusion. Of the 36 dogs with degenerative annular protrusions, seven were non-ambulatory at the time of presentation. Fifteen cases had multiple protrusions. Twenty dogs were managed non-surgically, 12 surgically and four were euthanased. A successful outcome was achieved in eight (22 per cent) cases as assessed by the authors and in 19 (52 per cent) cases as assessed by the owners. Mean follow-up time was 9.2 months (range 1.5 to 30 months). The outcome of dogs with annular protrusions was significantly worse compared to the outcome of dogs with nuclear extrusions (P<0.001).     

Hemilaminectomy for the treatment of thoracolumbar disc disease in the dog: a follow-uo studv of 40 cases

A study was made of dogs with Hansen type I thoracolumbar disc extrusions that had been treated by hemilaminectomy and fenestration of the affected disc. Follow-up information was available for 40 dogs undergoing treatment over a five-year period. The follow-up period ranged from 12 to 72 months (mean 34 months). The case details and the results of treatment of these 40 dogs are presented. All dogs were graded according to the degree of neurological dysfunction at the time of initial presentation and at the conclusion of the study period. Twenty-seven dogs (68 per cent) had no detectable signs of neurological dysfunction or thoracolumbar pain at the final assessment and a further eight dogs (20 per cent) had mild ambulatory paraparesis but were regarded by their owners as functional pets. Recurrence of neurological signs consistent with thoracolumbar disc disease was seen in five dogs (13 per cent) and was successfully resolved completely in one of three dogs that were treated.     

Analgesic effects of acupuncture in thoracolumbar disc disease in dogs

The analgesic effects of acupuncture were studied in 38 dogs affected by acute thoracolumbar disc disease, type I to IV. Steel acupuncture needles were inserted into selected acupuncture points. Stimulation time was 20 minutes. Electrical stimulation of needles, ear-acupuncture, vitamins B and C and antibiotics were occasionally used in some dogs of types I and II and in the majority of types III and IV. Pain relief was observed in 62.5 per cent of dogs of type I (back-pain), in 70.5 per cent of dogs of type II (hindlimb paresis, backpain) and in 39 per cent of dogs of types III and IV (hindlimb paralysis, backpain) after the first acupuncture treatment. Dogs of type I and II responded significantly better (P<0.01) than dogs of type III and IV at the fourth treatment (100 per cent and 61.5 per cent, respectively).     

Observations on acupuncture therapy of chronic osteoarthritis in dogs: a review of sixty-one cases

Weekly acupuncture needling was used in the treatment of osteoarthritis in 61 dogs. A total of 117 joints were treated, plus three vertebral columns. The results were evaluated on a five point scale. The average number of treatments per series was 5-2 and the average scale was 3–5. Hips, knees and shoulders responded better than the other joints. Some aspects of the mechanism of acupuncture in the treatment of osteoarthritis are described.     

245例犬细小病毒病发病及治疗情况分析

对泰州地区两动物医院1年期间收治的245例确诊犬细小病毒病病犬的发病情况及临床治疗效果进行统计比较和分析。结果显示:犬细小病毒病3~6月龄犬发病率最高,为5633%,12月龄以上的犬较少发病;经犬细小病毒单克隆抗体治疗后,2898%的病犬在2 d后康复,1960%的病犬3 d后康复,429%的病犬4 d后康复,1470%的病犬5 d后康复。     

The effectiveness of systemic antimicrobial treatment in canine superficial and deep pyoderma: a systematic review

Aim – To identify and evaluate existing evidence for the effectiveness of systemic antimicrobial treatments for naturally occurring superficial and deep canine pyoderma. Method – Electronic searches of PubMed, MEDLINE and CAB Direct were carried out (25 May 2011) without date or language restrictions. Proceedings of ESVD/ECVD, AAVD/ACVD, NAVDF and WCVD annual congresses were searched. Unpublished studies were sought via the Veterinary Dermatology discussion list and Veterinary Information Network. Results – Seventeen full‐length, peer‐reviewed controlled trials reporting clinical outcomes of systemic antimicrobial treatment for canine pyoderma were identified. Outcomes specific to superficial or deep pyoderma were reported in nine and five studies, respectively. Five studies reported outcomes only for nondifferentiated pyoderma depth. Heterogeneity of study designs and outcome measures made meta‐analysis inappropriate. A good level of evidence was identified supporting the high efficacy of subcutaneously injected cefovecin in superficial pyoderma and for oral amoxicillin–clavulanic acid in deep pyoderma. A fair level of evidence was identified for moderate to high efficacy of oral amoxicillin–clavulanic acid, clindamycin, cefadroxil, trimethoprim–sulphamethoxazole and sulfadimethoxine–ormetoprim in superficial pyoderma and oral pradofloxacin, oral cefadroxil and subcutaneously injected cefovecin in deep pyoderma. Eleven trials reported observations of adverse effects in treated pyoderma cases by intervention group; four dogs were withdrawn owing to the severity of adverse effects. Conclusions – There is a need for greater numbers of adequately sized, blinded, randomized controlled trials evaluating systemic antimicrobial interventions for canine pyoderma. Improved differentiation between superficial and deep pyoderma in outcome reporting, outcome measure standardization and association of outcomes with causative bacterial species and their resistance patterns are required.     

The future of immunotherapy for canine atopic dermatitis: a review

Allergen specific immunotherapy (ASIT) is a foundation treatment for canine atopic dermatitis (CAD), though few critical studies have documented its effectiveness as a disease‐modifying treatment in dogs. The mechanisms by which ASIT works in dogs have not been elucidated, although they are likely to parallel those known for humans. Current ASIT approaches in CAD focus on either subcutaneous or sublingual administration. Greater knowledge of major allergens in dogs, ideal dosage regimes and details of allergen admixture are likely to lead to better efficacy in CAD. Evaluation of biomarkers for successful therapy may also be of benefit. Potentially important advances in human medicine, that have yet to be explored in dogs, include use of modified allergen preparations such as allergoids, recombinant major allergens or allergen peptides; modification with adjuvants; or packaging of the above in virus‐like particles. Co‐administration of immunomodulators such as CpG oligodeoxynucleotides or specific monoclonal antibodies might direct the immune response in the desired direction while calming the “cytokine storm” of active disease. Initial trials of alternative routes of administration such as intralymphatic immunotherapy have yielded exciting results in humans, and continuing study in dogs is underway. Progress in ASIT of human food allergy may provide clues that will assist with improved diagnosis and patient management of CAD. Importantly, further study must be undertaken to clarify the conditions under which ASIT is a valuable treatment modality for dogs.